Stay updated on Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.5.2. This appears to be a minor site update with no visible changes to the study details.
    Difference
    0.1%
    Check dated 2026-04-16T11:05:17.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    The revision indicator was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T17:49:55.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was implemented, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:03:04.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Added a new site revision label Revision: v3.4.2, and removed the government funding status notice and the older Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T02:01:21.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding and current operating status added at the top with guidance to opm.gov; page revision updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:44:46.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Show glossary feature added; capitalization updated for 'Last Update Submitted that Met QC Criteria'; and new labels 'No FEAR Act Data' and 'Revision: v3.4.0' appear on the page. These are minor UI/label and versioning changes that do not alter core study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T23:45:29.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.